Extensive Alternative Splicing of the Repressor Element Silencing Transcription Factor Linked to Cancer

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Chen, Guo Lin ^a   Miller, Gregory M ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ADULT; AGED; ALTERNATIVE RNA SPLICING; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL TYPE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; EXON SKIPPING; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE TRANSLOCATION; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CANCER; LIVER CANCER; LIVER CARCINOGENESIS; LUNG CANCER; LUNG CARCINOGENESIS; MALE; MOLECULAR PATHOLOGY; MOUSE; NEOPLASM; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; RAT; REPRESSOR ELEMENT SILENCING TRANSCRIPTION FACTOR GENE; RHESUS MONKEY; RNA TRANSLATION; TISSUE SPECIFICITY; TRANSCRIPTION INITIATION SITE; TUMOR SUPPRESSOR GENE;

ALTERNATIVE SPLICING; EXONS; HUMANS; NEOPLASMS; REPRESSOR PROTEINS; TRANSCRIPTION FACTORS;

EID: 84876171528     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062217     Document Type: Article

References (57)

1. pone.0062217.1. Chen M, Manley JL (2009) Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches. Nat Rev Mol Cell Biol 10: 741-754.
2. Dutertre M, Sanchez G, Barbier J, Corcos L, Auboeuf D, (2011) The emerging role of pre-messenger RNA splicing in stress responses Sending alternative messages and silent messengers. Rna Biology 8: 740-747.
3. Oesterreich FC, Bieberstein N, Neugebauer KM, (2011) Pause locally, splice globally. Trends in Cell Biology 21: 328-335.
4. Alló M, Schor IE, Muñoz MJ, de la Mata M, Agirre E, et al. (2010) Chromatin and Alternative Splicing. Cold Spring Harbor Symposia on Quantitative Biology 75: 103-111.
5. Schwartz S, Meshorer E, Ast G, (2009) Chromatin organization marks exon-intron structure. Nat Struct Mol Biol 16: 990-995.
6. Luco RF, Allo M, Schor IE, Kornblihtt AR, Misteli T, (2011) Epigenetics in Alternative Pre-mRNA Splicing. Cell 144: 16-26.
7. Anastasiadou C, Malousi A, Maglaveras N, Kouidou S, (2011) Human Epigenome Data Reveal Increased CpG Methylation in Alternatively Spliced Sites and Putative Exonic Splicing Enhancers. DNA and Cell Biology 30: 267-275.
8. Sanchez SE, Petrillo E, Beckwith EJ, Zhang X, Rugnone ML, et al. (2010) A methyl transferase links the circadian clock to the regulation of alternative splicing. Nature 468: 112-116.
9. Nijholt I, Farchi N, Kye M, Sklan EH, Shoham S, et al. (2003) Stress-induced alternative splicing of acetylcholinesterase results in enhanced fear memory and long-term potentiation. Mol Psychiatry 9: 174-183.
10. Sumanasekera C, Watt DS, Stamm S, (2008) Substances that can change alternative splice-site selection. Biochemical Society Transactions 36: 483-490.
11. Wang G-S, Cooper TA, (2007) Splicing in disease: disruption of the splicing code and the decoding machinery. Nat Rev Genet 8: 749-761.
12. Kim S, Kim H, Fong N, Erickson B, Bentley DL, (2011) Pre-mRNA splicing is a determinant of histone H3K36 methylation. Proceedings of the National Academy of Sciences 108: 13564-13569.
13. Tazi J, Bakkour N, Stamm S, (2009) Alternative splicing and disease. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1792: 14-26.
14. Padgett RA, (2012) New connections between splicing and human disease. Trends in Genetics 28: 147-154.
15. Chong JA, Tapia-Ramirez J, Kim S, Toledo-Aral JJ, Zheng Y, et al. (1995) REST: A mammalian silencer protein that restricts sodium channel gene expression to neurons. Cell 80: 949-957.
16. Schoenherr CJ, Anderson DJ, (1995) The Neuron-Restrictive Silencer Factor (Nrsf)-A Coordinate Repressor Of Multiple Neuron-Specific Genes. Science 267: 1360-1363.
17. Ooi L, Wood IC, (2007) Chromatin crosstalk in development and disease: lessons from REST. Nature Reviews Genetics 8: 544-554.
18. Weissman AM, (2008) How much REST is enough? Cancer Cell 13: 381-383.
19. Majumder S, (2006) REST in good times and bad-Roles in tumor suppressor and oncogenic activities. Cell Cycle 5: 1929-1935.
20. Westbrook TF, Hu G, Ang XLL, Mulligan P, Pavlova NN, et al. (2008) SCF beta-TRCP controls oncogenic transformation and neural differentiation through REST degradation. Nature 452: 370-U311.
21. Buckley NJ, Johnson R, Zuccato C, Bithell A, Cattaneo E, (2010) The role of REST in transcriptional and epigenetic dysregulation in Huntington's disease. Neurobiology of Disease 39: 28-39.
22. Shimojo M, Paquette AJ, Anderson DJ, Hersh LB, (1999) Protein kinase A regulates cholinergic gene expression in PC12 cells: REST4 silences the silencing activity of neuron-restrictive silencer factor/REST. Molecular and Cellular Biology 19: 6788-6795.
23. Lee JH, Chai YG, Hersh LB, (2000) Expression patterns of mouse repressor element-1 silencing transcription factor 4 (REST4) and its possible function in neuroblastoma. Journal of Molecular Neuroscience 15: 205-214.
24. Kuwabara T, Hsieh J, Nakashima K, Taira K, Gage FH, (2004) A small modulatory dsRNA specifies the fate of adult neural stem cells. Cell 116: 779-793.
25. Bruce AW, López-Contreras AJ, Flicek P, Down TA, Dhami P, et al. (2009) Functional diversity for REST (NRSF) is defined by in vivo binding affinity hierarchies at the DNA sequence level. Genome Research 19: 994-1005.
26. Wagoner MP, Gunsalus KTW, Schoenike B, Richardson AL, Friedl A, et al. (2010) The Transcription Factor REST Is Lost in Aggressive Breast Cancer. PLoS Genet 6: e1000979.
27. Palm K, Metsis M, Timmusk T, (1999) Neuron-specific splicing of zinc finger transcription factor REST/NRSF/XBR is frequent in neuroblastomas and conserved in human, mouse and rat. Molecular Brain Research 72: 30-39.
28. Coulson JM, Edgson JL, Woll PJ, Quinn JP, (2000) A Splice Variant of the Neuron-restrictive Silencer Factor Repressor Is Expressed in Small Cell Lung Cancer: A Potential Role in Derepression of Neuroendocrine Genes and a Useful Clinical Marker. Cancer Research 60: 1840-1844.
29. Uchida S, Hara K, Kobayashi A, Funato H, Hobara T, et al. (2010) Early Life Stress Enhances Behavioral Vulnerability to Stress through the Activation of REST4-Mediated Gene Transcription in the Medial Prefrontal Cortex of Rodents. The Journal of Neuroscience 30: 15007-15018.
30. Cai L, Bian M, Liu M, Sheng Z, Suo H, et al. (2011) Ethanol-Induced Neurodegeneration In Nrsf/Rest Neuronal Conditional Knockout Mice. Neuroscience 181: 196-205.
31. Abramovitz L, Shapira T, Ben-Dror I, Dror V, Granot L, et al. (2008) Dual role of NRSF/REST in activation and repression of the glucocorticoid response. Journal of Biological Chemistry 283: 110-119.
32. Shimojo M, Lee JH, Hersh LB, (2001) Role of zinc finger domains of the transcription factor neuron-restrictive silencer factor/repressor element-1 silencing transcription factor in DNA binding and nuclear localization. Journal of Biological Chemistry 276: 13121-13126.
33. Shimojo M, (2006) Characterization of the nuclear targeting signal of REST/NRSF. Neuroscience Letters 398: 161-166.
34. Fogg MH, Wirth LJ, Posner M, Wang F, (2009) Decreased EBNA-1-specific CD8+ T cells in patients with Epstein-Barr virus-associated nasopharyngeal carcinoma. Proceedings of the National Academy of Sciences 106: 3318-3323.
35. White L, Eaton M, Castro M, Klose K, Globus M, et al. (1994) Distinct regulatory pathways control neurofilament expression and neurotransmitter synthesis in immortalized serotonergic neurons. The Journal of Neuroscience 14: 6744-6753.
36. Sheridan SD, Theriault KM, Reis SA, Zhou F, Madison JM, et al. (2011) Epigenetic Characterization of the FMR1 Gene and Aberrant Neurodevelopment in Human Induced Pluripotent Stem Cell Models of Fragile X Syndrome. PLoS ONE 6: e26203.
37. Chen GL, Vallender EJ, Miller GM, (2008) Functional characterization of the human TPH2 5′ regulatory region: untranslated region and polymorphisms modulate gene expression in vitro. Human Genetics 122: 645-657.
38. Livak KJ, Schmittgen TD, (2001) Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2-ΔΔCT Method. Methods 25: 402-408.
39. Kolanczyk M, Pech M, Zemojtel T, Yamamoto H, Mikula I, et al. (2011) NOA1 is an essential GTPase required for mitochondrial protein synthesis. Molecular Biology of the Cell 22: 1-11.
40. Grommes C, Landreth GE, Heneka MT, (2004) Antineoplastic effects of peroxisome proliferatoractivated receptor γ agonists. The Lancet Oncology 5: 419-429.
41. Murphy GJ, Holder JC, (2000) PPAR-γ agonists: therapeutic role in diabetes, inflammation and cancer. Trends in Pharmacological Sciences 21: 469-474.
42. Kojima T, Murai K, Naruse Y, Takahashi N, Mori N, (2001) Cell-type non-selective transcription of mouse and human genes encoding neural-restrictive silencer factor. Molecular Brain Research 90: 174-186.
43. Westbrook TF, Martin ES, Schlabach MR, Leng YM, Liang AC, et al. (2005) A genetic screen for candidate tumor suppressors identifies REST. Cell 121: 837-848.
44. Faghihi MA, Wahlestedt C, (2009) Regulatory roles of natural antisense transcripts. Nat Rev Mol Cell Biol 10: 637-643.
45. Heidler J, Al-Furoukh N, Kukat C, Salwig I, Ingelmann M-E, et al. (2011) Nitric Oxide-associated Protein 1 (NOA1) Is Necessary for Oxygen-dependent Regulation of Mitochondrial Respiratory Complexes. Journal of Biological Chemistry 286: 32086-32093.
46. Parihar MS, Parihar A, Chen Z, Nazarewicz R, Ghafourifar P, (2008) mAtNOS1 regulates mitochondrial functions and apoptosis of human neuroblastoma cells. Biochimica et Biophysica Acta (BBA)-General Subjects 1780: 921-926.
47. Jiang M, Strand DW, Franco OE, Clark PE, Hayward SW, (2011) PPARγ: A molecular link between systemic metabolic disease and benign prostate hyperplasia. Differentiation 82: 220-236.
48. Fuller GN, Su XH, Price RE, Cohen ZR, Lang FF, et al. (2005) Many human medulloblastoma tumors overexpress repressor element-1 silencing transcription (REST) neuron-restrictive silencer factor, which can be functionally countered by REST-VP16. Molecular Cancer Therapeutics 4: 343-349.
49. Taylor P, Fangusaro J, Rajaram V, Goldman S, Helenowski IB, et al. (2012) REST Is a Novel Prognostic Factor and Therapeutic Target for Medulloblastoma. Molecular Cancer Therapeutics 11: 1713-1723.
50. Tsukahara T, (2012) The Role of PPARγ in the Transcriptional Control by Agonists and Antagonists. PPAR Research 2012: 9.
51. Rosen ED, Spiegelman BM, (2001) PPARγ: a Nuclear Regulator of Metabolism, Differentiation, and Cell Growth. Journal of Biological Chemistry 276: 37731-37734.
52. Skelhorne-Gross G, Nicol CJB, (2012) The Key to Unlocking the Chemotherapeutic Potential of PPARγ Ligands: Having the Right Combination. PPAR Research 2012: 13.
53. Azoulay L, Yin H, Filion KB, Assayag J, Majdan A, et al. (2012) The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study. British Medical Journal 344.
54. Bruce AW, Donaldson IJ, Wood IC, Yerbury SA, Sadowski MI, et al. (2004) Genome-wide analysis of repressor element 1 silencing transcription factor/neuron-restrictive silencing factor (REST/NRSF) target genes. Proceedings of the National Academy of Sciences of the United States of America 101: 10458-10463.
55. Seyfried T, Shelton L, (2010) Cancer as a metabolic disease. Nutrition & Metabolism 7: 7.
56. Kalonia H, Kumar P, Kumar A, (2010) Pioglitazone ameliorates behavioral, biochemical and cellular alterations in quinolinic acid induced neurotoxicity: Possible role of peroxisome proliferator activated receptor-Gamma (PPAR Gamma) in Huntington's disease. Pharmacology Biochemistry and Behavior 96: 115-124.
57. Chiang M-C, Chern Y, Huang R-N, (2012) PPARgamma rescue of the mitochondrial dysfunction in Huntington's disease. Neurobiology of Disease 45: 322-328.